Literature DB >> 33597222

DNA mismatch repair proteins: scientific update and practical guide.

Adrian C Bateman1.   

Abstract

DNA mismatch repair (MMR) proteins are essential for the recognition and correction of sporadic genetic mutations that occur during DNA replication. Deficient MMR function (dMMR) leads to an increased risk of development of neoplasia. Identification of dMMR within tumours can suggest a high chance of the inherited cancer condition Lynch syndrome and predicts poor clinical response to certain conventional chemotherapies but an increased likelihood of response to immunotherapy. This review provides an update on the biology of MMR proteins, their encoding genes and mechanisms for the development of dMMR. This is followed by a discussion of the identification and significance of dMMR in routine clinical practice. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  DNA; carcinoma; colorectal neoplasms; genes; immunohistochemistry; neoplasm

Year:  2021        PMID: 33597222     DOI: 10.1136/jclinpath-2020-207281

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Unraveling the Molecular Impact of Sperm DNA Damage on Human Reproduction.

Authors:  Renata Finelli; Bruno P Moreira; Marco G Alves; Ashok Agarwal
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Role of AI and digital pathology for colorectal immuno-oncology.

Authors:  Mohsin Bilal; Mohammed Nimir; David Snead; Graham S Taylor; Nasir Rajpoot
Journal:  Br J Cancer       Date:  2022-10-01       Impact factor: 9.075

Review 3.  Bacterial Involvement in Progression and Metastasis of Colorectal Neoplasia.

Authors:  Kevin D Seely; Amanda D Morgan; Lauren D Hagenstein; Garrett M Florey; James M Small
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

Review 4.  Role of mismatch repair in aging.

Authors:  Jie Wen; Yangyang Wang; Minghao Yuan; Zhenting Huang; Qian Zou; Yinshuang Pu; Bin Zhao; Zhiyou Cai
Journal:  Int J Biol Sci       Date:  2021-09-21       Impact factor: 6.580

5.  Efficacy and Safety of Neoadjuvant Monoimmunotherapy With PD-1 Inhibitor for dMMR/MSI⁃H Locally Advanced Colorectal Cancer: A Single-Center Real-World Study.

Authors:  Xuan Zhang; Renfang Yang; Tao Wu; Xinyi Cai; Guoyu Li; Kun Yu; Yong Li; Rong Ding; Chao Dong; Jinsha Li; Ruixi Hu; Qing Feng; Yunfeng Li
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

6.  Isolated MLH1 Loss by Immunohistochemistry Because of Benign Germline MLH1 Polymorphisms.

Authors:  Dustin E Bosch; Matthew M Yeh; Stephen J Salipante; Angela Jacobson; Stacey A Cohen; Eric Q Konnick; Vera A Paulson
Journal:  JCO Precis Oncol       Date:  2022-08

Review 7.  DNA repair as a shared hallmark in cancer and ageing.

Authors:  Thomas L Clarke; Raul Mostoslavsky
Journal:  Mol Oncol       Date:  2022-07-28       Impact factor: 7.449

8.  PTPRD/PTPRT mutation as a predictive biomarker of immune checkpoint inhibitors across multiple cancer types.

Authors:  Xiaoling Shang; Wengang Zhang; Xun Zhang; Miao Yu; Jingwen Liu; Yufeng Cheng; Bo Cheng
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

Review 9.  Genetic risk factors in melanoma etiopathogenesis and the role of genetic counseling: A concise review.

Authors:  Nikola Serman; Semir Vranic; Mislav Glibo; Ljiljana Serman; Zrinka Bukvic Mokos
Journal:  Bosn J Basic Med Sci       Date:  2022-09-16       Impact factor: 3.759

10.  Primary small bowel adenocarcinoma with loss of nuclear expression of PMS2 after resection of mucinous cholangiocarcinoma.

Authors:  Ateeqa Mujeeb Ullah; Anna Jaysing; Hassan Raza Hashmi; Amir Humza Sohail; Wendi Li; John D Allendorf; Suparna A Sarkar
Journal:  J Surg Case Rep       Date:  2022-01-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.